The FELIXA Sirolimus Eluting Coronary Stent System is an advanced product in the second-generation Sirolimus Eluting Stent. FELIXA stent is a combination of a stent framework of cobalt-chromium material, Sirolimus - a clinically proven inhibitor of cell proliferation - along with a biodegradable polymer carrier system.

The new coating technology with single-sided coating and the ability to control the release time stabilizes the clinical effectiveness of the product.

FELIXA significantly improves the "Safety - Efficiency and Accessibility" when performing Percutaneous Coronary Intervention (PCI), optimizing clinical results in the treatment of coronary artery disease, significantly improves blood vessel diameter and minimizes re-stenosis in the stent during the procedures.